Cutera Future Growth
Future criteria checks 0/6
Cutera is forecast to grow earnings and revenue by 26.5% and 2.4% per annum respectively while EPS is expected to grow by 34.7% per annum.
Key information
26.5%
Earnings growth rate
34.7%
EPS growth rate
Medical Equipment earnings growth | 14.2% |
Revenue growth rate | 2.4% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 11 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 160 | -75 | N/A | N/A | 3 |
12/31/2025 | 146 | -82 | N/A | N/A | 4 |
12/31/2024 | 141 | -110 | N/A | N/A | 4 |
9/30/2024 | 155 | -144 | -120 | -117 | N/A |
6/30/2024 | 169 | -149 | -138 | -129 | N/A |
3/31/2024 | 197 | -158 | -161 | -138 | N/A |
12/31/2023 | 212 | -163 | -171 | -138 | N/A |
9/30/2023 | 230 | -113 | -160 | -121 | N/A |
6/30/2023 | 247 | -81 | -143 | -104 | N/A |
3/31/2023 | 249 | -95 | -107 | -74 | N/A |
12/31/2022 | 252 | -82 | -90 | -67 | N/A |
9/30/2022 | 251 | -78 | -62 | -47 | N/A |
6/30/2022 | 245 | -68 | -43 | -34 | N/A |
3/31/2022 | 240 | -13 | -31 | -30 | N/A |
12/31/2021 | 231 | 2 | 0 | 1 | N/A |
9/30/2021 | 216 | 8 | 2 | 3 | N/A |
6/30/2021 | 197 | 7 | 5 | 6 | N/A |
3/31/2021 | 165 | -12 | -5 | -4 | N/A |
12/31/2020 | 148 | -24 | -18 | -17 | N/A |
9/30/2020 | 150 | -28 | -19 | -17 | N/A |
6/30/2020 | 157 | -29 | -17 | -16 | N/A |
3/31/2020 | 178 | -17 | -7 | -6 | N/A |
12/31/2019 | 182 | -12 | -3 | -2 | N/A |
9/30/2019 | 175 | -37 | 1 | 2 | N/A |
6/30/2019 | 170 | -35 | 2 | 3 | N/A |
3/31/2019 | 165 | -37 | 1 | 2 | N/A |
12/31/2018 | 163 | -31 | -1 | 0 | N/A |
9/30/2018 | 165 | 18 | -3 | -1 | N/A |
6/30/2018 | 162 | 25 | N/A | 4 | N/A |
3/31/2018 | 156 | 29 | N/A | 8 | N/A |
12/31/2017 | 151 | 30 | N/A | 14 | N/A |
9/30/2017 | 142 | 11 | N/A | 12 | N/A |
6/30/2017 | 134 | 7 | N/A | 10 | N/A |
3/31/2017 | 125 | 4 | N/A | 2 | N/A |
12/31/2016 | 118 | 3 | N/A | 2 | N/A |
9/30/2016 | 110 | 0 | N/A | 1 | N/A |
6/30/2016 | 103 | -2 | N/A | -1 | N/A |
3/31/2016 | 98 | -3 | N/A | 1 | N/A |
12/31/2015 | 95 | -4 | N/A | -1 | N/A |
9/30/2015 | 90 | -8 | N/A | -5 | N/A |
6/30/2015 | 86 | -10 | N/A | -5 | N/A |
3/31/2015 | 81 | -11 | N/A | -9 | N/A |
12/31/2014 | 78 | -11 | N/A | -4 | N/A |
9/30/2014 | 75 | -9 | N/A | -2 | N/A |
6/30/2014 | 73 | -8 | N/A | -1 | N/A |
3/31/2014 | 75 | -6 | N/A | 3 | N/A |
12/31/2013 | 75 | -5 | N/A | 4 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: TJ9 is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: TJ9 is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: TJ9 is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: TJ9's revenue (2.4% per year) is forecast to grow slower than the German market (5.6% per year).
High Growth Revenue: TJ9's revenue (2.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if TJ9's Return on Equity is forecast to be high in 3 years time